Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2006 | |
| Sales | 164,849 | 44,682 | 20,719 | 19,660 | 0 |
| Gross Profit | 164,849 | 44,682 | 20,719 | 19,660 | N/A |
| Operating Expenses | 130,902 | 101,108 | 61,912 | 50,985 | 0 |
| Operating Income | 33,947 | -56,426 | -41,193 | -31,325 | N/A |
| Interest Expense | 3,836 | 3,389 | 2,811 | 2,086 | 0 |
| Other Income | 537 | 1,026 | -189 | 938 | 0 |
| Pre-tax Income | 30,648 | -58,789 | -44,193 | -32,473 | 0 |
| Income Tax | N/A | N/A | -100 | N/A | N/A |
| Net Income Continuous | 30,648 | -58,789 | -44,093 | -32,473 | N/A |
| Net Income | $30,648 | $-58,789 | $-44,093 | $-32,473 | $N/A |
| EPS Basic Total Ops | 7.70 | -23.00 | -274.30 | -210.80 | N/A |
| EPS Basic Continuous Ops | 7.72 | -22.98 | -274.38 | -210.73 | N/A |
| EPS Diluted Total Ops | 7.40 | -23.00 | -274.30 | -210.80 | N/A |
| EPS Diluted Continuous Ops | 7.39 | -22.98 | -274.38 | -210.73 | N/A |
| EBITDA(a) | $39,402 | $-54,672 | $-39,531 | $-30,500 | $N/A |